急性肝毒性の潜在的未認識リスク:最近のアロプリノールとコルキシンを開始した後のフルミナント肝不全の症例報告
Nicholas Looby1, Cole D Tessendorf1, Jack Hagen2
1University of South Dakota Sanford School of Medicine.
まとめ
このケースは,特に腎臓疾患の患者で,アロプリノールとコルキシンによる重度の肝損傷の可能性を強調しています. 早期のモニタリングは 高リスクの患者に 痛風の薬を投与する際に重要です
科学分野:
- ヘパトロジー
- 腎臓科
- 臨床薬理学
背景:
- 薬剤による肝損傷 (DILI) は急性肝不全の重要な原因です.
- アロプリノールとコルキシンは一般的に痛風に使用されますが,稀に fulminant 肝不全に関連しています.
- 慢性腎疾患 (CKD) の患者は,薬物の代謝と分泌が変化している可能性があります.
研究 の 目的:
- 肝臓が急激に衰え 死に至った
- 慢性腎臓病患者におけるアロプリノールとコルキシンの潜在的肝毒性を調査する.
- 高リスク患者の肝機能の認識とモニタリングの必要性を強調する
主な方法:
- ケースレポートのプレゼンテーション
- 臨床経過と検査結果の見直し
- 薬剤投与と有害事象の時間分析
主要な成果:
- アロプリノールとコルキシン投与開始後数日で,CKD第3段階の男性患者が発症した.
- 患者は多臓器不全と死亡まで急速に進行した.
- 偶然の食道腫が認められたが,その役割は不明である.
結論:
- このケースは,特に腎機能不全の患者において,アロプリノールとコルキシンの潜在的肝毒性に関する懸念を提起する.
- 時間の関連は これらの薬と重度の肝損傷の間の 可能性のある関連を示唆しています
- 肝機能の早期モニタリングは,これらの薬を開始する高リスクの患者に推奨されます.
関連する概念動画
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
158
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
158
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
137
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
137
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
765
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
765
01:29Drugs for Treatment of Ulcerative Colitis in IBD
373
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
373
01:17Chronic Bowel Disorders: Introduction
696
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
696
01:11Renal Failure: Dose Adjustments
355
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
355